• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天冬酰胺-甘氨酸-精氨酸(NGR)肿瘤新生血管归巢基序的免疫原性和结构特性。

Immunogenic and structural properties of the Asn-Gly-Arg (NGR) tumor neovasculature-homing motif.

作者信息

Di Matteo Paola, Curnis Flavio, Longhi Renato, Colombo Giorgio, Sacchi Angelina, Crippa Luca, Protti Maria Pia, Ponzoni Mirco, Toma Salvatore, Corti Angelo

机构信息

Department of Biological and Technological Research, San Raffaele H Scientific Institute, 20132 Milan, Italy.

出版信息

Mol Immunol. 2006 Apr;43(10):1509-18. doi: 10.1016/j.molimm.2005.10.009. Epub 2005 Dec 7.

DOI:10.1016/j.molimm.2005.10.009
PMID:16337683
Abstract

Tumor homing peptides containing the NGR motif, such as CNGRC and GNGRG, have been used for delivering cytokines, chemotherapeutic drugs, apoptotic peptides, and liposomes to a CD13 isoform expressed in tumor blood vessels. In view of the potential clinical applications of these drugs and considering the risk that NGR peptides could elicit blocking antibodies we have investigated the immunogenic properties of CNGRC and GNGRG in mice and rabbits, using various products containing these residues and different administration schedules. The results suggest that the immunogenicity of the NGR motif is very low, even when it is conjugated to tumor necrosis factor-alpha or to highly immunogenic carrier proteins. Molecular dynamics simulation experiments showed that both peptides have a strong propensity to populate a turn conformation. Superposition of predicted structures to the CTGNGRGEWKC loop of the 5th type I repeat of human fibronectin, a protein that contains four NGR motives, showed that the root mean square deviation of backbones was 0.7A for GNGRG and 0.5A for NGR. These results suggest that NGR peptides could mimic from an immunological point of view a "self" structure, likely the GNGRG loop of fibronectin, with important implications for the use of these targeting peptides in patients.

摘要

含有NGR基序的肿瘤归巢肽,如CNGRC和GNGRG,已被用于将细胞因子、化疗药物、凋亡肽和脂质体递送至肿瘤血管中表达的CD13同种型。鉴于这些药物的潜在临床应用,并考虑到NGR肽可能引发阻断抗体的风险,我们使用含有这些残基的各种产品和不同的给药方案,研究了CNGRC和GNGRG在小鼠和兔子中的免疫原性。结果表明,即使NGR基序与肿瘤坏死因子-α或高免疫原性载体蛋白偶联,其免疫原性也非常低。分子动力学模拟实验表明,这两种肽都有强烈的倾向形成转角构象。将预测结构与人纤连蛋白第5个I型重复序列的CTGNGRGEWKC环(一种含有四个NGR基序的蛋白质)叠加,结果显示,GNGRG的主链均方根偏差为0.7埃,NGR为0.5埃。这些结果表明,从免疫学角度来看,NGR肽可能模拟一种“自身”结构,可能是人纤连蛋白的GNGRG环,这对这些靶向肽在患者中的应用具有重要意义。

相似文献

1
Immunogenic and structural properties of the Asn-Gly-Arg (NGR) tumor neovasculature-homing motif.天冬酰胺-甘氨酸-精氨酸(NGR)肿瘤新生血管归巢基序的免疫原性和结构特性。
Mol Immunol. 2006 Apr;43(10):1509-18. doi: 10.1016/j.molimm.2005.10.009. Epub 2005 Dec 7.
2
Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells.含NGR基序的药物与肿瘤血管、上皮细胞和髓样细胞中CD13亚型的差异结合。
Cancer Res. 2002 Feb 1;62(3):867-74.
3
Structure-activity relationships of linear and cyclic peptides containing the NGR tumor-homing motif.
J Biol Chem. 2002 Dec 6;277(49):47891-7. doi: 10.1074/jbc.M207500200. Epub 2002 Oct 7.
4
Tumor vascular targeting with tumor necrosis factor alpha and chemotherapeutic drugs.利用肿瘤坏死因子α和化疗药物进行肿瘤血管靶向治疗。
Ann N Y Acad Sci. 2004 Dec;1028:104-12. doi: 10.1196/annals.1322.011.
5
Critical role of flanking residues in NGR-to-isoDGR transition and CD13/integrin receptor switching.侧翼残基在 NGR 到 isoDGR 的转变以及 CD13/整合素受体转换中的关键作用。
J Biol Chem. 2010 Mar 19;285(12):9114-23. doi: 10.1074/jbc.M109.044297. Epub 2010 Jan 11.
6
An NGR-integrated and enediyne-energized apoprotein shows CD13-targeting antitumor activity.一种整合了 NGR 并被烯二炔类化合物激活的载脂蛋白具有针对 CD13 的抗肿瘤活性。
Biomed Pharmacother. 2013 Mar;67(2):164-71. doi: 10.1016/j.biopha.2012.10.018. Epub 2012 Nov 19.
7
NGR enhanced the anti-angiogenic activity of tum-5.NGR增强了tum-5的抗血管生成活性。
J Biochem. 2006 Aug;140(2):299-304. doi: 10.1093/jb/mvj152. Epub 2006 Jul 14.
8
NGR peptide ligands for targeting CD13/APN identified through peptide array screening resemble fibronectin sequences.通过肽阵列筛选鉴定的靶向 CD13/APN 的 NGR 肽配体类似于纤连蛋白序列。
ACS Comb Sci. 2012 Nov 12;14(11):590-9. doi: 10.1021/co300055s. Epub 2012 Oct 11.
9
Isoaspartate-glycine-arginine: a new tumor vasculature-targeting motif.异天冬氨酸-甘氨酸-精氨酸:一种新的肿瘤血管靶向基序。
Cancer Res. 2008 Sep 1;68(17):7073-82. doi: 10.1158/0008-5472.CAN-08-1272.
10
Solution state conformation and degradation of cyclopeptides containing an NGR motif.
J Pept Sci. 2005 Jan;11(1):53-9. doi: 10.1002/psc.588.

引用本文的文献

1
Radiolabeled NGR-Based Heterodimers for Angiogenesis Imaging: A Review of Preclinical Studies.用于血管生成成像的放射性标记基于NGR的异二聚体:临床前研究综述
Cancers (Basel). 2023 Sep 7;15(18):4459. doi: 10.3390/cancers15184459.
2
Targeting the Blood-Brain Tumor Barrier with Tumor Necrosis Factor-α.利用肿瘤坏死因子-α靶向血脑肿瘤屏障
Pharmaceutics. 2022 Jul 6;14(7):1414. doi: 10.3390/pharmaceutics14071414.
3
Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment.
植物成分的抗癌活性及其针对肿瘤细胞和微环境的脂质体靶向策略。
Adv Drug Deliv Rev. 2020;154-155:245-273. doi: 10.1016/j.addr.2020.05.006. Epub 2020 May 28.
4
Targeting Tumors Using Peptides.利用肽靶向肿瘤。
Molecules. 2020 Feb 13;25(4):808. doi: 10.3390/molecules25040808.
5
A-NGR fusion protein induces apoptosis in human cancer cells.A-NGR融合蛋白可诱导人类癌细胞凋亡。
EXCLI J. 2018 Jun 25;17:590-597. doi: 10.17179/excli2018-1120. eCollection 2018.
6
Succinimide Formation from an NGR-Containing Cyclic Peptide: Computational Evidence for Catalytic Roles of Phosphate Buffer and the Arginine Side Chain.含NGR环肽形成琥珀酰亚胺:磷酸盐缓冲液和精氨酸侧链催化作用的计算证据
Int J Mol Sci. 2017 Feb 16;18(2):429. doi: 10.3390/ijms18020429.
7
Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarction.阿霉素与经肿瘤内截留的阿霉素重定向组织因子的组合效应以及肿瘤血管梗死的促凋亡增加。
Oncotarget. 2016 Dec 13;7(50):82458-82472. doi: 10.18632/oncotarget.12559.
8
A unified mechanism for aminopeptidase N-based tumor cell motility and tumor-homing therapy.基于氨肽酶N的肿瘤细胞运动性和肿瘤归巢治疗的统一机制。
J Biol Chem. 2014 Dec 12;289(50):34520-9. doi: 10.1074/jbc.M114.566802. Epub 2014 Oct 29.
9
Immunomodulatory Agents with Antivascular Activity in the Treatment of Non-Small Cell Lung Cancer: Focus on TLR9 Agonists, IMiDs and NGR-TNF.具有抗血管活性的免疫调节剂在非小细胞肺癌治疗中的应用:聚焦 TLR9 激动剂、IMiDs 和 NGR-TNF。
J Oncol. 2010;2010:732680. doi: 10.1155/2010/732680. Epub 2010 Jun 3.
10
Structure and activity of CPNGRC: a modified CD13/APN peptidic homing motif.CPNGRC 的结构和活性:一种修饰的 CD13/APN 肽同源基序。
Chem Biol Drug Des. 2010 Jun;75(6):551-62. doi: 10.1111/j.1747-0285.2010.00974.x. Epub 2010 Mar 30.